The promise and the reality of viral vaccines against cancer.
Hilleman
M R
MR
Merck Institute for Therapeutic Research, Merck Research Laboratories, West Point, Pennsylvania 19486.
D000818:Animals; D016174:Hepacivirus / Q000276:immunology; D006509:Hepatitis B / Q000517:prevention & control; D006514:Hepatitis B Surface Antigens / Q000737:chemistry / Q000276:immunology; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D016233:Immunotherapy, Active; D009369:Neoplasms / Q000628:therapy*; D014765:Viral Vaccines / Q000266:history / Q000276:immunology
D006514:Hepatitis B Surface Antigens; D014765:Viral Vaccines